Hemodynamic Effects of Intermittent Pneumatic Compression for Sports (IPC)

University of Maia

Status: Completed

Conditions: Sports Physical Therapy

Treatments: Device: Intermittent pneumatic compression (AirRelax)

Study type: Interventional

Funder types: Other

Identifiers

NCT06168565

0000001231

Details and patient eligibility

About

The aim of this randomized crossover trial is to assess the hemodynamic effects caused by the use of 2 distinct intermittent pneumatic compression protocols on athletes.

The main questions it aims to answer are:

• Does intermittent pneumatic compression enhance athletes blood flow?
• If yes, what pressure is better to cause this enhancement?

Enrollment: 23 patients

Sex: Male

Ages: 18 to 26 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• male gender
• healthy
• competing in soccer of track and field for at least two years
• not have performed any physical activity on the data collection day

Exclusion criteria

• more than one risk factor for thromboembolism (e.g., use of tobacco, varicose veins)
• injured athletes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

23 participants in 2 patient groups

Sequence 1

Experimental group

Description:

Measures of end-diastolic peak velocity, systolic peak velocity, heart rate, and arterial diameter will be collected for two minutes, two minutes before, at the 8th minute after the start of the IPC administration, and two minutes after the conclusion of each IPC protocol. End-diastolic peak velocity and systolic peak velocity will be measured across different phases of the IPC cycle (all cuffs inflated, half of the cuffs inflated, and all cuffs deflated). Both the athletes and assessors will be unaware of which protocol is being carried out. All protocols will be performed with participants lying down in a supine position, on a stretcher. The moderate pressure protocol applies a pressure of 80mmHg and the high pressure protocol applies a pressure of 200mmHg.

Treatment:

Device: Intermittent pneumatic compression (AirRelax)

Sequence 2

Experimental group

Description:

Measures of end-diastolic peak velocity, systolic peak velocity, heart rate, and arterial diameter will be collected for two minutes, two minutes before, at the 8th minute after the start of the IPC administration, and two minutes after the conclusion of each IPC protocol. End-diastolic peak velocity and systolic peak velocity will be measured across different phases of the IPC cycle (all cuffs inflated, half of the cuffs inflated, and all cuffs deflated). Both the athletes and assessors will be unaware of which protocol is being carried out. All protocols will be performed with participants lying down in a supine position, on a stretcher. The moderate pressure protocol applies a pressure of 80mmHg and the high pressure protocol applies a pressure of 200mmHg.

Treatment:

Device: Intermittent pneumatic compression (AirRelax)